The ABCs of Transitioning PK Assays from Preclinical to Clinical
Worldwide Clinical Trials
SEPTEMBER 29, 2022
a typical format is: receptor/target as capture with a generic binding reagent as detection (e.g., Special reagents must be designed that are specific for the investigational drug and will not cross-react with naturally occurring human immunoglobulins. anti-human IgG).
Let's personalize your content